DEVELOPMENTAL EFFECTS OF PRENATAL CANNABINOID EXPOSURE
DEVELOPMENTAL EFFECTS OF PRENATAL CANNABINOID EXPOSURE
批准号:
2123811
负责人:
Laura Murphy
金额:
$10.65万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-06-05 至 2000-05-31
关键词:
B lymphocyte T lymphocyte blood chemistry cannabinoid receptor cannabinoids cellular immunity dosage embryo /fetus drug adverse effect gender difference hypothalamic pituitary adrenal axis immune system laboratory rat lymphocyte proliferation neuroendocrine system pituitary adrenal axis pregnancy prenatal growth disorder radioimmunoassay secretion spleen steroid hormone thymus
中文摘要
描述(改编自研究者摘要):本学术
研究促进奖(区域)的建议解决了产前的影响
暴露于δ-9-四氢大麻酚(THC)对神经内分泌和
免疫系统的发展和成年男性和女性后代。
尽管怀孕期间接触大麻已被证明会产生
对后代的长期神经内分泌影响,对
免疫系统尚未被研究。 在初步研究中,
大麻的主要精神活性成分,用于怀孕的老鼠
在怀孕的最后一周,已被证明会扰乱荷尔蒙
母亲和胎儿的环境。 因为发育中的免疫系统
胎儿的神经内分泌系统容易受到激素变化的影响,
在这个时候,暴露于THC的男性和女性后代可能
免疫和神经内分泌功能受损。 事实上,初步
研究结果支持这一假设,因为胸腺和脾脏重量
在发育过程中和成年雄性和雌性中显著改变
后代 此外,下丘脑神经递质含量,催乳素
水平和交配行为参数也受到影响,
在子宫内接触四氢大麻酚的后代 胸腺和脾脏的变化
体重是否反映了免疫功能的改变 是神经内分泌轴
(下丘脑-垂体-肾上腺和性腺),
影响免疫系统的功能,由于暴露而受损
在中枢神经系统发育的关键阶段对四氢大麻酚的反应 在这项提案中,
申请人将通过以下方式检查这些问题:1)测量广泛的
THC的剂量范围(0.5-10 mg/kg)在产前给予免疫和
发育和成年后代的神经内分泌参数。 因为只有一个
将浓度为5 mg/kg的THC施用给初步大鼠
到目前为止,测试更宽剂量范围的影响将提供重要的
剂量反应数据,并允许在未来使用THC的最佳剂量
研究; 2)确定产前THC暴露对胎儿发育能力的影响。
T和B细胞对特定的有丝分裂原作出反应。 测量
丝裂原诱导的淋巴细胞增殖反应,
发育中和成年雄性和雌性后代的胸腺和脾脏将
传递关于基本免疫能力的重要信息; 3)检查
发育过程中和成年时胸腺和脾脏组织的组织学
在子宫内暴露于载体或THC的雄性和雌性后代; 4)确定
如果在子宫内暴露于THC会改变下丘脑-垂体-肾上腺和/或
- 雄性和雌性后代的性腺功能。 这些结果一起
将提供新的和急需的信息,
THC宫内暴露对免疫和神经内分泌功能的影响
这反过来又将导致更好地了解产妇药物滥用
及其对雄性和雌性后代的影响。
英文摘要
DESCRIPTION (Adapted from the Investigator's Abstract): This Academic
Research Enhancement Award (AREA) proposal addresses the effects of prenatal
exposure to delta-9-tetrahydrocannabinol (THC) on the neuroendocrine and
immune systems of the developing and adult male and female offspring.
Although marijuana exposure during pregnancy has been shown to produce
long-lasting neuroendocrine effects in the offspring, possible effects on
the immune system have not been studied. In preliminary studies, THC, the
major psychoactive component of marijuana, administered to pregnant rats
during the last week of gestation, has been shown to disturb the hormonal
milieu of mother and fetus. Because the developing immune and
neuroendocrine systems of the fetus are vulnerable to changes in the hormone
environment at this time, the male and female offspring exposed to THC may
have compromised immune and neuroendocrine function. Indeed, preliminary
findings support this hypothesis in that thymus and spleen weights were
significantly altered during development and in adult male and female
offspring. Moreover, hypothalamic neurotransmitter content, prolactin
levels, and copulatory behavior parameters were also affected in the
offspring exposed to THC in utero. Do the changes in thymus and spleen
weight reflect alterations in immune function? Are the neuroendocrine axes
(hypothalamic-pituitary-adrenal and -gonadal) that directly and indirectly
affect the function of the immune system compromised as a result of exposure
to THC during a critical stage of CNS development? In this proposal the
applicant will examine these questions by 1) measuring the effects of a wide
dose range of THC (0.5-10 mg/kg) administered prenatally on immune and
neuroendocrine parameters of developing and adult offspring. As only one
concentration of THC (5 mg/kg) has been administered to preliminary rats
thus far, testing the effects of a wider dose range will provide important
dose-response data and allow optimal doses of THC to be utilized in future
studies; 2) Determine the effects of prenatal THC exposure on the ability of
T and B cells to respond to specific mitogens. Measuring the
mitogen-induced proliferation responses of Iymphocytes obtained from the
thymus and spleen of developing and adult male and female offspring will
impart important information concerning basic immunocompetence; 3) Examine
the histology of thymus and spleen tissues during development and in adult
male and female offspring exposed to vehicle or THC in utero; 4) Determine
if in utero exposure to THC alters hypothalamic-pituitary-adrenal and/or
-gonadal function of the male and female offspring. Together, these results
will provide new and much-needed information concerning the potential
effects of in utero THC exposure on immune and neuroendocrine function
which, in turn, will lead to a better understanding of maternal drug abuse
and its effects on male and female offspring.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ginseng and its Constituents in Complementary Breast Cancer Therapy
-
批准号:7662927
-
项目类别:
-
资助金额:$18.19万
-
财政年份:2009
-
负责人:Laura Murphy
-
依托单位:
Ginseng and its Constituents in Complementary Breast Cancer Therapy
-
批准号:7841949
-
项目类别:
-
资助金额:$21.83万
-
财政年份:2009
-
负责人:Laura Murphy
-
依托单位:
Anti-Cancer Ginsenosides: Their Interactions and Mechanisms of Action
-
批准号:7080968
-
项目类别:
-
资助金额:$15.63万
-
财政年份:2006
-
负责人:Laura Murphy
-
依托单位:
Anti-Cancer Ginsenosides: Their Interactions and Mechanisms of Action
-
批准号:7230117
-
项目类别:
-
资助金额:$13.33万
-
财政年份:2006
-
负责人:Laura Murphy
-
依托单位:
Adjuvant Ginseng Use During Breast Cancer Drug Therapy
-
批准号:6873769
-
项目类别:
-
资助金额:$21.45万
-
财政年份:2004
-
负责人:Laura Murphy
-
依托单位:
Adjuvant Ginseng Use During Breast Cancer Drug Therapy
-
批准号:6765038
-
项目类别:
-
资助金额:$17.88万
-
财政年份:2004
-
负责人:Laura Murphy
-
依托单位:
CANNABINOIDS AND THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS
-
批准号:2901925
-
项目类别:
-
资助金额:$12.92万
-
财政年份:1999
-
负责人:Laura Murphy
-
依托单位:
CANNABINOIDS AND THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS
-
批准号:6174989
-
项目类别:
-
资助金额:$13.31万
-
财政年份:1999
-
负责人:Laura Murphy
-
依托单位:
CANNABINOIDS AND THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS
-
批准号:6515564
-
项目类别:
-
资助金额:$14.12万
-
财政年份:1999
-
负责人:Laura Murphy
-
依托单位:
CANNABINOIDS AND THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS
-
批准号:6378648
-
项目类别:
-
资助金额:$13.71万
-
财政年份:1999
-
负责人:Laura Murphy
-
依托单位:
NEUROENDOCRINE MECHANISMS OF CANNABINOID ACTION
-
批准号:3461121
-
项目类别:
-
资助金额:$8.29万
-
财政年份:1989
-
负责人:Laura Murphy
-
依托单位:
NEUROENDOCRINE MECHANISMS OF CANNABINOID ACTION
-
批准号:2117674
-
项目类别:
-
资助金额:$8.12万
-
财政年份:1989
-
负责人:Laura Murphy
-
依托单位:
NEUROENDOCRINE MECHANISMS OF CANNABINOID ACTION
-
批准号:3461122
-
项目类别:
-
资助金额:$10.56万
-
财政年份:1989
-
负责人:Laura Murphy
-
依托单位:
NEUROENDOCRINE MECHANISMS OF CANNABINOID ACTION
-
批准号:3461124
-
项目类别:
-
资助金额:$11.64万
-
财政年份:1989
-
负责人:Laura Murphy
-
依托单位:
NEUROENDOCRINE MECHANISMS OF CANNABINOID ACTION
-
批准号:3461123
-
项目类别:
-
资助金额:$11.22万
-
财政年份:1989
-
负责人:Laura Murphy
-
依托单位:
海外基金